Cardiovascular Systems, Inc. to Participate at Two Upcoming Healthcare Conferences

ST. PAUL, Minn.--(BUSINESS WIRE)-- Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, today announced that management plans to present and host investor meetings at two upcoming healthcare conferences. Live webcasts and replays of the presentations will be available on the investor relations section of the corporate website.

21st Annual Needham Virtual Healthcare Conference
Tuesday, April 12, 2022
10:15 a.m. ET

BofA Securities 2022 Healthcare Conference
Tuesday, May 10, 2022
4:00 p.m. ET

About Cardiovascular Systems, Inc.

Cardiovascular Systems, Inc., based in St. Paul, Minn., is a medical device company focused on developing and commercializing innovative solutions for treating vascular and coronary disease. The company’s orbital atherectomy system treats calcified and fibrotic plaque in arterial vessels throughout the leg and heart and addresses many of the limitations associated with existing surgical, catheter and pharmacological treatment alternatives. For additional information, please visit www.csi360.com and connect on Twitter @csi360.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220322005859/en/

Cardiovascular Systems, Inc.
Jack Nielsen
Vice President, Investor Relations
& Corporate Communications
(651) 202-4919
[email protected]

Source: Cardiovascular Systems, Inc.

You May Also Be Interested In

• DEVAL Solutions, Inc Launches PHASE — The First Centralized MOR Compliance Platform for HUD Project Based Section 8 Housing
• Compliance Group Launches AI Agents for Life Sciences to Accelerate Quality Reviews, Strengthen Audit Readiness, and Reduce Validation Time
• Saptalis Pharmaceuticals and Coformer AI Partner to Develop Next-Generation Drug Formulations for Neurology and Oncology